Breaking News Instant updates and real-time market news.

CBS

CBS

$57.58

0.55 (0.96%)

15:27
10/09/18
10/09
15:27
10/09/18
15:27

Insiders say CBS will look at possible sale after completing probe, FBN reports

Charles Gasparino of Fox Business Network tweeted: "@CBS tells employees in memo that it has interviewed more than 150 people in sexual harassment probe implores employees to come forward. insiders say after investigation, company will look at possible sale" Reference Link

  • 01

    Nov

CBS CBS
$57.58

0.55 (0.96%)

09/26/18
RILY
09/26/18
UPGRADE
Target $39
RILY
Buy
Viacom upgraded to Buy from Neutral at B. Riley FBR
B.Riley/FBR analyst Barton Crockett upgraded Viacom (VIAB) to Buy with a $39 price target. The analyst also keeps a Buy rating on CBS (CBS) and raised his price target for the shares to $63 from $61.
09/18/18
IMPC
09/18/18
NO CHANGE
Target $71
IMPC
Outperform
Market ignoring fundamental catalysts for CBS, says Imperial Capital
Imperial Capital analyst David Miller says he has increased conviction in shares of CBS following a call with interim CEO Joe Ianiello. The market is focusing "way too much" on the management changes as well as prospects of a re-merger with Viacom (VIAB), and ignoring all the fundamental catalysts central to CBS, "of which there are many," Miller tells investors in a research note. These include a "political advertising windfall" in Q4, CBS' broadcast of the Superbowl on February 3, 2019, and higher rate card growth for retransmission consent for approximately 75% of CBS' owned and operated station economics over the next two fiscal years, Miller contends. He keeps an Outperform rating on CBS with a $71 price target.
09/11/18
09/11/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. TESLA, CBS DOWNGRADED ON MANAGEMENT CONCERNS: Nomura Instinet analyst Romit Shah downgraded Tesla (TSLA) to Neutral from Buy and cut his price target for the shares to $300 from $400. Shah expressed concern that the "erratic behavior" of CEO Elon Musk will taint the Tesla brand. Shah, who admits to being one of the most bullish analysts on Wall Street since initiating the stock in October of 2017, still believes Tesla could grow to be a much larger company. The analyst, however, prefers to move to the sidelines pending potential changes in management. UBS analyst John Hodulik downgraded CBS Corporation (CBS) to Neutral from Buy and lowered his price target for the shares to $60 from $72. Uncertainty around the management transition limits upside in the shares and could last for an extended period, Hodulik said. The analyst said that while interim CEO Joseph Ianniello has a strong track record as COO, he does not expect him to be appointed as the permanent replacement since controlling shareholder National Amusements noted in court filings that it does not see him as a potential successor to Les Moonves. In late morning trading, Tesla is down 3.6%, while CBS is down almost 1%. CANACCORD UPGRADES NIKE TO BUY: Canaccord analyst Camilo Lyon upgraded Nike (NKE) to Buy from Hold. The analyst believes Nike has regained its footing and is marching back to form following two years of a soft product cycle, margin compression, and market share declines. He cited newly introduced platforms coupled with forthcoming innovations as catalysts to sustain earnings growth. Lyon raised his price target to $95 from $78 on Nike shares. ROSENBLATT BOOSTS AMD PRICE TARGET: Rosenblatt analyst Hans Mosesmann raised Buy rated AMD's price target to $40 from $30 citing a faster ramp in 7nm GPU compute. Mosesmann said AMD's move over the past several quarters reminds him of the setup Nvidia (NVDA) experienced almost three years ago when it transformed from a PC graphics play to a "compute powerhouse." GOLDMAN UPGRADES DARDEN, CUTS WINGSTOP: Goldman Sachs analyst Karen Holthouse did a ratings restack in Americas Restaurants, which included upgrading Darden Restaurants (DRI) to Buy from Neutral, upgrading Bloomin' Brands (BLMN) to Neutral from Sell, and downgrading Wingstop (WING) to Sell from Neutral.
09/11/18
09/11/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. CBS (CBS) downgraded to Neutral from Buy at UBS with analyst John Hodulik saying uncertainty around the management transition limits upside in the shares and could last for an extended period. 2. Tesla (TSLA) downgraded to Neutral from Buy at Nomura Instinet with analyst Romit Shah expressing concern that the "erratic behavior" of CEO Elon Musk will taint the Tesla brand. 3. Johnson Controls (JCI) downgraded to Neutral from Buy at UBS with analyst Steven Winoker saying while the company's Buildings business is improving in 2018, the pace and magnitude of the progress is proving slower and lower than expectations. 4. Wingstop (WING) downgraded to Neutral from Buy at Goldman Sachs with analyst Karen Holthouse saying she continues to view the company's comps and unit growth fundamentals favorably but she recommends taking profits at current share levels. 5. AAR Corp. (AIR) downgraded to Hold from Buy at SunTrust with analyst Michael Ciarmoli saying he is maintaining a bullish view on the aero aftermarket with an opportunity for AAR Corp to exploit its position while also reaping benefits from its INL Global Aviation Support Services contract, but he also believes that the company's near-term growth will come under pressure from its maintenance, repair, and overhaul, or MRO, segment. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

NDSN

Nordson

$138.81

-0.42 (-0.30%)

16:33
02/20/19
02/20
16:33
02/20/19
16:33
Hot Stocks
Nordson reports Q1 backlog $439M, up 9% from last year. »

CEO Michael Hilton said:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

SNPS

Synopsys

$102.98

1.08 (1.06%)

16:33
02/20/19
02/20
16:33
02/20/19
16:33
Hot Stocks
Breaking Hot Stocks news story on Synopsys »

Synopsys sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 03

    Mar

  • 08

    Mar

  • 14

    Mar

  • 17

    Mar

  • 16

    Jul

  • 17

    Jul

  • 26

    Sep

  • 27

    Sep

SNPS

Synopsys

$102.98

1.08 (1.06%)

16:32
02/20/19
02/20
16:32
02/20/19
16:32
Earnings
Synopsys sees FY19 adjusted EPS $4.20-$4.27, consensus $4.24 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 03

    Mar

  • 08

    Mar

  • 14

    Mar

  • 17

    Mar

  • 16

    Jul

  • 17

    Jul

  • 26

    Sep

  • 27

    Sep

SAM

Boston Beer

$267.95

-0.97 (-0.36%)

16:32
02/20/19
02/20
16:32
02/20/19
16:32
Earnings
Boston Beer sees FY19 EPS $8.00-$9.00, consensus $8.51 »

Sees FY19 national price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

SUI

Sun Communities

$114.00

-0.61 (-0.53%)

16:32
02/20/19
02/20
16:32
02/20/19
16:32
Earnings
Sun Communities reports Q4 FFO $1.03, consensus $1.03 »

Reports Q4 revenue $274M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TS

Tenaris

$27.38

0.48 (1.78%)

16:32
02/20/19
02/20
16:32
02/20/19
16:32
Earnings
Tenaris reports Q4 EPS 38c, consensus 43c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    May

NDSN

Nordson

$138.81

-0.42 (-0.30%)

16:31
02/20/19
02/20
16:31
02/20/19
16:31
Earnings
Nordson reports Q1 adjusted EPS 92c, consensus $1.12 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

SNPS

Synopsys

$102.98

1.08 (1.06%)

16:31
02/20/19
02/20
16:31
02/20/19
16:31
Earnings
Synopsys sees Q2 adjusted EPS $1.07-$1.12, consensus $1.05 »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 03

    Mar

  • 08

    Mar

  • 14

    Mar

  • 17

    Mar

  • 16

    Jul

  • 17

    Jul

  • 26

    Sep

  • 27

    Sep

OMCL

Omnicell

$84.04

1.04 (1.25%)

16:31
02/20/19
02/20
16:31
02/20/19
16:31
Conference/Events
Omnicell management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 30

    May

SAM

Boston Beer

$267.95

-0.97 (-0.36%)

16:30
02/20/19
02/20
16:30
02/20/19
16:30
Earnings
Boston Beer reports Q4 EPS $1.86, consensus $1.70 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

HCSG

Healthcare Services

$39.96

-0.37 (-0.92%)

16:30
02/20/19
02/20
16:30
02/20/19
16:30
Conference/Events
Healthcare Services management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

16:30
02/20/19
02/20
16:30
02/20/19
16:30
Options
Preliminary option volume of 17.7M today »

Preliminary option volume…

SNPS

Synopsys

$102.98

1.08 (1.06%)

16:29
02/20/19
02/20
16:29
02/20/19
16:29
Earnings
Synopsys reports Q1 EPS $1.08, consensus 97c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 03

    Mar

  • 08

    Mar

  • 14

    Mar

  • 17

    Mar

  • 16

    Jul

  • 17

    Jul

  • 26

    Sep

  • 27

    Sep

WK

Workiva

$44.27

0.48 (1.10%)

16:29
02/20/19
02/20
16:29
02/20/19
16:29
Earnings
Workiva sees FY19 adjusted EPS (39c)-(34c), consensus (30c) »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

UFPI

Universal Forest

$32.68

-0.12 (-0.37%)

16:29
02/20/19
02/20
16:29
02/20/19
16:29
Earnings
Universal Forest reports Q4 EPS 50c, consensus 52c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WRI

Weingarten Realty

$29.56

-0.27 (-0.91%)

16:29
02/20/19
02/20
16:29
02/20/19
16:29
Earnings
Weingarten Realty sees FY19 FFO $2.09-$2.17, consensus $2.23 »

Sees same-store NOIC up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

WK

Workiva

$44.27

0.48 (1.10%)

16:28
02/20/19
02/20
16:28
02/20/19
16:28
Earnings
Workiva sees Q1 adjusted EPS (5c)-(4c), consensus (6c) »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

CYH

Community Health

$4.07

0.09 (2.26%)

16:28
02/20/19
02/20
16:28
02/20/19
16:28
Earnings
Community Health reports Q4 adjusted EPS (42c), consensus (58c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WRI

Weingarten Realty

$29.56

-0.27 (-0.91%)

16:28
02/20/19
02/20
16:28
02/20/19
16:28
Earnings
Weingarten Realty reports Q4 FFO 55c, consensus 57c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

WK

Workiva

$44.27

0.48 (1.10%)

16:28
02/20/19
02/20
16:28
02/20/19
16:28
Earnings
Workiva reports Q4 adjusted EPS 0c, consensus (10c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

GHDX

Genomic Health

$83.70

1.11 (1.34%)

16:28
02/20/19
02/20
16:28
02/20/19
16:28
Earnings
Genomic Health sees FY19 EPS $1.38-$1.54, consensus $1.25 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

RPT

Ramco-Gershenson

$13.33

-0.07 (-0.52%)

16:27
02/20/19
02/20
16:27
02/20/19
16:27
Earnings
Breaking Earnings news story on Ramco-Gershenson »

Ramco-Gershenson sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

RBBN

Ribbon Communications

$6.06

-0.08 (-1.30%)

16:27
02/20/19
02/20
16:27
02/20/19
16:27
Earnings
Ribbon Communications reports Q4 adjusted EPS 26c, consensus 25c »

Reports Q4 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 06

    Mar

WPX

WPX Energy

$13.40

0.16 (1.21%)

16:26
02/20/19
02/20
16:26
02/20/19
16:26
Earnings
WPX Energy reports Q4 adjusted EPS 2c, consensus 6c »

Reports Q4 product…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

CAR

Avis Budget

$29.35

-0.23 (-0.78%)

16:26
02/20/19
02/20
16:26
02/20/19
16:26
Hot Stocks
Breaking Hot Stocks news story on Avis Budget »

Avis Budget higher by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 20

    Mar

  • 21

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.